In PAH patients with a TET2 mutation compared to PAH patients without mutation, 1917 DMRs were identified 904 of which were uniquely hypermethylated (Figure 2B; Data S3 and S4). This evidence concerns the gene TET2 and pulmonary arterial hypertension.